Swiss drugmaker Novartis reports a sharp fall in profits, due in part to manufacturing problems at a US plant and to currency moves.

Read more here:
Novartis sees profit fall sharply

The pharmaceutical company Novartis is challenging the use of a cheaper alternative to its drug Lucentis for a common cause of loss of vision.

Link:
NHS faces challenge over eye drug

Get ready to answer back to your medicine. Swiss drug makers Novartis AG plan to seek regulatory approval in Europe in the next 18 months for a tablet that contains an embedded microchip. The ingestible chip would be activated by stomach acid and send…

Continued here:
New Pill Developed With Microchip

The company joins a growing list of pharmaceutical companies that have been accused by federal prosecutors of illegally promoting drugs for off-label purposes.

Read more from the original source:
Novartis Pays $422.5 Million in Settlement